AKR1B10 and metabolic dysfunction-associated steatohepatitis: This AKR1B10 overexpression, together with the underexpression of ALDHs (1A2 and 1A3) [111] and HSD17B14 [115], may reduce hepatic retinal levels, and hence lead to a decrease in retinoic acid, favoring progression of NASH to HCC.